Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting; Amendment, 14212 [2017-05347]

Download as PDF 14212 Federal Register / Vol. 82, No. 51 / Friday, March 17, 2017 / Notices osd.pentagon.ousd-p-r.mbx.familyreadiness-council@mail.mil. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C. Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150. Pursuant to 5 U.S.C. 552b and 41 CFR 102–3.140 through 102–3.165, this meeting is open to the public, subject to the availability of space. Members of the public who are entering the Pentagon should arrive at the Pentagon Visitors Center waiting area (Pentagon Metro entrance) at 12:00 p.m. on the day of the meeting to allow time to pass through security check points and to be escorted to the meeting location. Members of the public need to email their RSVP to the Council at osd.pentagon.ousd-prmbx.family-readiness-council@mail.mil no later than 5:00 p.m. on Thursday, April 20, 2017 to confirm seating availability, to request an escort, and to request handicapped accessible transportation (cart) if needed. Pursuant to 41 CFR 102–3.105(j) and 102–3.140, and section 10(a)(3) of the Federal Advisory Committee Act of 1972, interested persons may submit a written statement for review and consideration by submitting it to the Council’s email address, osd.pentagon.ousd-p-r.mbx.familyreadiness-council@mail.mil. The deadline for written submissions is 5:00 p.m. on Thursday, April 13, 2017 which is two weeks prior to the meeting date. The purpose of this meeting is to receive information related to community collaboratives, policies, programs and services that provide relocation information and support services to DoD Service and family members throughout their mobile military lifecycle. asabaliauskas on DSK3SPTVN1PROD with NOTICES Thursday, April 27, 2017 Meeting Agenda Welcome & Administrative Remarks. The Impact of Relocation on Service and Family Members. High Tech/High Touch Relocation Collaboratives and Support Services. Minnesota’s Beyond the Yellow Ribbon Support for the National Guard and Reserve. Military OneSource Central Information and Referral Dissemination Point. Military Service Relocation Best Practices (Panel). Closing Remarks. Note: Exact order may vary. VerDate Sep<11>2014 20:02 Mar 16, 2017 Jkt 241001 Dated: March 14, 2017. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2017–05368 Filed 3–16–17; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting; Amendment Assistant Secretary of Defense (Health Affairs), Department of Defense. ACTION: Notice of meeting; amendment. AGENCY: On Wednesday, February 15, 2017 (82 FR 10762), the Department of Defense published a notice announcing a Federal Advisory Committee Meeting of the Uniform Formulary Beneficiary Advisory Panel. Subsequent to the publication of the notice, an item was added to the Meeting Agenda. All other information in the February 15, 2017 notice remains the same. DATES: Wednesday, March 22, 2017, from 9:00 a.m. to 12:00 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: CAPT Edward Norton, DFO, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Telephone: (703) 681–2890. Fax: (703) 681–1940. Email Address: dha.ncr.health-it.mbx.baprequests@ mail.mil. SUMMARY: Due to circumstances beyond the control of the Designated Federal Officer and the Department of Defense, the Uniform Formulary Beneficiary Advisory Panel was unable to provide public notification concerning a change to a previously announced meeting agenda for a meeting on March 22, 2017, of the Uniform Formulary Beneficiary Advisory Panel as required by 41 CFR 102–3.150(a). Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 CFR 102–3.150(b), waives the 15calendar day notification requirement. This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150, the Department of Defense announces that an item in the Meeting Agenda has changed. The revised Meeting Agenda reads as follows: Agenda 1. Sign-In 2. Welcome and Opening Remarks 3. Public Citizen Comments 4. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item) a. Hepatitis C Agents—Direct Acting Antivirals b. Antibiotics—Tetracyclines c. Proton Pump Inhibitors 5. Recently Approved Drugs Review 6. Pertinent Utilization Management Issues 7. Panel Discussions and Vote Dated: March 13, 2017. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2017–05347 Filed 3–16–17; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF ENERGY Federal Energy Regulatory Commission [Project No. 2788–017] Goodyear Lake Hydro, LLC; Notice of Application Tendered for Filing With the Commission and Soliciting Additional Study Requests and Establishing Procedural Schedule for Relicensing and a Deadline for Submission of Final Amendments Take notice that the following hydroelectric application has been filed with the Commission and is available for public inspection. a. Type of Application: Subsequent Minor License. b. Project No.: 2788–017. c. Date filed: February 27, 2017. d. Applicant: Goodyear Lake Hydro, LLC (Goodyear Lake Hydro). e. Name of Project: Colliersville Hydroelectric Project. f. Location: On the North Branch of the Susquehanna River, in the Town of Milford, Otsego County, New York. The project does not occupy lands of the United States. g. Filed Pursuant to: Federal Power Act 16 U.S.C. 791 (a)–825(r). h. Applicant Contact: Mr. Kevin Webb, Hydro Licensing Manager; Enel E:\FR\FM\17MRN1.SGM 17MRN1

Agencies

[Federal Register Volume 82, Number 51 (Friday, March 17, 2017)]
[Notices]
[Page 14212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05347]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting; Amendment

AGENCY: Assistant Secretary of Defense (Health Affairs), Department of 
Defense.

ACTION: Notice of meeting; amendment.

-----------------------------------------------------------------------

SUMMARY: On Wednesday, February 15, 2017 (82 FR 10762), the Department 
of Defense published a notice announcing a Federal Advisory Committee 
Meeting of the Uniform Formulary Beneficiary Advisory Panel. Subsequent 
to the publication of the notice, an item was added to the Meeting 
Agenda. All other information in the February 15, 2017 notice remains 
the same.

DATES: Wednesday, March 22, 2017, from 9:00 a.m. to 12:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: CAPT Edward Norton, DFO, Uniform 
Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 
5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. Fax: 
(703) 681-1940. Email Address: dha.ncr.health-it.mbx.baprequests@mail.mil.

SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of 
the Designated Federal Officer and the Department of Defense, the 
Uniform Formulary Beneficiary Advisory Panel was unable to provide 
public notification concerning a change to a previously announced 
meeting agenda for a meeting on March 22, 2017, of the Uniform 
Formulary Beneficiary Advisory Panel as required by 41 CFR 102-
3.150(a). Accordingly, the Advisory Committee Management Officer for 
the Department of Defense, pursuant to 41 CFR 102-3.150(b), waives the 
15-calendar day notification requirement.
    This meeting is being held under the provisions of the Federal 
Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), 
the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), 
and 41 CFR 102-3.140.
    Under the provisions of the Federal Advisory Committee Act of 1972 
(5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, the Department 
of Defense announces that an item in the Meeting Agenda has changed.
    The revised Meeting Agenda reads as follows:

Agenda

1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Hepatitis C Agents--Direct Acting Antivirals
    b. Antibiotics--Tetracyclines
    c. Proton Pump Inhibitors
5. Recently Approved Drugs Review
6. Pertinent Utilization Management Issues
7. Panel Discussions and Vote

    Dated: March 13, 2017.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2017-05347 Filed 3-16-17; 8:45 am]
 BILLING CODE 5001-06-P